The bias against new innovations in health care: value uncertainty and willingness to pay.
This paper offers a model for the bias found in willingness-to-pay valuations against new treatments. For example, this bias provides an explanation for patient preferences that make it difficult for formularies to take treatments off their lists, even when newer treatments would appear to be clearly preferable. The appeal of the model, which is based on imperfect information, is that it is consistent with rational preferences and rational behavior by patients, which are necessary for standard models and methods related to decision theory, cost-effectiveness, and efficiency.
Walton
Surrey M
SM
Department of Pharmacy Administration, University of Illinois, Chicago, Illinois 60612-7231, USA. Walton@uic.edu
Graves
Philip E
PE
Mueser
Peter R
PR
Dow
Jay K
JK
D001290:Attitude; D003362:Cost-Benefit Analysis; D003662:Decision Theory; D004059:Diffusion of Innovation; D005382:Financing, Personal; D006301:Health Services Needs and Demand / Q000191:economics*; D006302:Health Services Research; D006801:Humans; D018803:Models, Economic; D010342:Patient Acceptance of Health Care